JENNIFER COMPTON: Open Payments
NPI 1174560361 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 114 payments from 12 companies in 2025. Trend: 2023 $2,296 · 2024 $3,198 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 68 | $374 |
| Janssen Biotech, Inc. | 9 | $183 |
| ABBVIE INC. | 14 | $162 |
| PFIZER INC. | 6 | $140 |
| Boston Scientific Corporation | 3 | $107 |
| COLOPLAST CORP | 5 | $92 |
| UROGEN PHARMA, INC. | 2 | $44 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: GEMTESA, ERLEADA, XTANDI, Axonics, BOTOX, LUPRON DEPOT, ORGOVYX, Luja Coude.
Industry payments across OK — which companies pay providers there.
